Neuronetics, Inc.
Neuronetics, Inc. (STIM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · STIM · as of Jun 8, 2026
Key Statistics
Explore Neuronetics, Inc. Data
stim stock data · financialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 71.4%
The STIM analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $8.00, representing +525.00% upside from the current price of $1.28.
Competitors & Peers
stim competitorsSTIM
ATLN
CATX
CDXS
GNFT
NYXHAbout Neuronetics, Inc.
Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencin…
what is neuronetics, inc. · stim stock overview · neuronetics, inc. company profile · who is neuronetics, inc. ceo · stim NASDAQ · neuronetics, inc. headquarters · neuronetics, inc. business segments
About Stock Overview & Key Data
Neuronetics, Inc. (STIM) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Jun 28, 2018. As of the latest trading session, STIM stock price is $1.28, with a market capitalization of $89.1M. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, Neuronetics, Inc. (STIM) stock price is $1.28. The stock is traded on NASDAQ under the ticker symbol STIM. The 52-week range is $0.80 – $4.85.